This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Grand Mal Status Epilepticus or Non-convulsive Status Epilepticus
and you are
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

Identify the most effective dose of valproic acid when used in combination with phenytoin for treatment of patients with refractory status epilepticus, which allow a better clinical course and prognosis of the disease.

Provided treatments

  • Drug: valproic acid (VPA)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01586208. The sponsor of the trial is Hospital Universitari de Bellvitge and it is looking for 5 volunteers for the current phase.
Official trial title:
Refractory Status Epilepticus: Plasmatic Levels Monitorization Utility